Biotest AG VZ Stock
Price
Target price
€28.10
€28.10
-1.420%
-0.4
-1.420%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Biotest
sharewise wants to provide you with the best news and tools for Biotest, so we directly link to the best financial data sources.
Financials
News
EQS-News: Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July
EQS-News: Strategic agreement signed for distribution of Yimmugo® in the United States based on the framework established in July
EQS-News: Change in the Chief Financial Officer at Biotest AG
EQS-News: Change in the Chief Financial Officer at Biotest AG
EQS-News: Biotest AG opens 13th plasma collection center in Germany
EQS-News: Biotest AG opens 13th plasma collection center in Germany
EQS-News: Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG
EQS-News: Dr. Jörg Schüttrumpf resigns from the Management Board of Biotest AG
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Biotest increases sales in the first half of 2024 by 35% to Euro 372 million
EQS-News: Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
EQS-News: Biotest prepares launch of its immunoglobulin Yimmugo in the USA, establishing a framework for a strategic billion-dollar distribution agreement with Kedrion
EQS-News: Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'
EQS-News: Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds'
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
EQS-News: Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo
EQS-News: Biotest AG: Annual General Meeting approves dividend distribution
EQS-News: Biotest AG: Annual General Meeting approves dividend distribution
EQS-News: Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024
EQS-News: Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024
EQS-News: Biotest AG opens 12th plasma collection centre in Germany
EQS-News: Biotest AG opens 12th plasma collection centre in Germany